Drug
Daivobet
Daivobet: highest development phase Phase 2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Daivobet® ointment NCT00845481 | Phase 2 | Psoriasis Vulgaris |
Latest
No recent events.
Follow Daivobet on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.